Fabrizio De Ponti
Fabrizio De Ponti
Professor of Pharmacology, University of Bologna
Verified email at unibo.it
Cited by
Cited by
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers
A Cavalli, E Poluzzi, F De Ponti, M Recanatini
Journal of medicinal chemistry 45 (18), 3844-3853, 2002
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview
F De Ponti, E Poluzzi, A Cavalli, M Recanatini, N Montanaro
Drug Safety 25 (4), 263-286, 2002
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini, L Cipollina, E Poluzzi, F Crema, GR Corazza, F De Ponti
Alimentary pharmacology & therapeutics 19 (4), 379-390, 2004
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
F De Ponti, E Poluzzi, N Montanaro
European journal of clinical pharmacology 56 (1), 1-18, 2000
QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development
M Recanatini, E Poluzzi, M Masetti, A Cavalli, F De Ponti
Medicinal research reviews 25 (2), 133-166, 2005
Inflammatory neuropathies of the enteric nervous system
R De Giorgio, S Guerrini, G Barbara, V Stanghellini, F De Ponti, ...
Gastroenterology 126 (7), 1872-1883, 2004
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome
C Cremon, G Carini, B Wang, V Vasina, RF Cogliandro, R De Giorgio, ...
Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011
Irritable bowel syndrome
F De Ponti, M Tonini
Drugs 61 (3), 317-332, 2001
Enteric neuroplasticity evoked by inflammation
V Vasina, G Barbara, L Talamonti, V Stanghellini, R Corinaldesi, M Tonini, ...
Autonomic Neuroscience 126, 264-272, 2006
Cardiac adverse effects of gastrointestinal prokinetics
D Ponti, D Nucci
Alimentary pharmacology & therapeutics 13 (12), 1585-1591, 1999
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus
F De Ponti, E Poluzzi, N Montanaro
European journal of clinical pharmacology 57 (3), 185-209, 2001
Pharmacology of serotonin: what a clinician should know
F De Ponti
Gut 53 (10), 1520-1535, 2004
Anticancer drugs and cardiotoxicity: insights and perspectives in the era of targeted therapy
E Raschi, V Vasina, MG Ursino, G Boriani, A Martoni, F De Ponti
Pharmacology & therapeutics 125 (2), 196-218, 2010
The β3-adrenoceptor as a therapeutic target: current perspectives
MG Ursino, V Vasina, E Raschi, F Crema, F De Ponti
Pharmacological research 59 (4), 221-234, 2009
Drug‐induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)
E Poluzzi, E Raschi, U Moretti, F De Ponti
Pharmacoepidemiology and drug safety 18 (6), 512-518, 2009
Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA adverse event reporting system (AERS)
E Poluzzi, E Raschi, C Piccinni, F De Ponti
Data mining applications in engineering and medicine, 2012
Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.
E Poluzzi, E Raschi, D Motola, U Moretti, F De Ponti
Drug safety 33 (4), 303-314, 2010
The hERG K+ channel: target and antitarget strategies in drug development
E Raschi, V Vasina, E Poluzzi, F De Ponti
Pharmacological research 57 (3), 181-195, 2008
Plasticity in the enteric nervous system
C Giaroni, F De Ponti, M Cosentino, S Lecchini, G Frigo
Gastroenterology 117 (6), 1438-1458, 1999
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective
E Poluzzi, C Piccinni, E Raschi, A Rampa, M Recanatini, F De Ponti
Current medicinal chemistry 21 (4), 417-436, 2014
The system can't perform the operation now. Try again later.
Articles 1–20